Recombinant human FGF-2 for the treatment of early-stage osteonecrosis of the femoral head: TRION, a single-arm, multicenter, Phase II trial

Regenerative Medicine, Ahead of Print.

Source: Future Medicine: Regenerative Medicine - June 2, 2021 Category: Genetics & Stem Cells Authors: Yutaka Kuroda Takeyuki Tanaka Takaki Miyagawa Hidetoshi Hamada Hiroyasu Abe Toshiko Ito-Ihara Ryuta Asada Yusuke Fujimoto Daisuke Takahashi Tomonori Tetsunaga Ayumi Kaneuji Michiaki Takagi Yutaka Inaba Satoshi Morita Nobuhiko Sugano Sakae Tanaka Shuichi M Source Type: research